Heck Capital Advisors, LLC Harmony Biosciences Holdings, Inc. Transaction History
Heck Capital Advisors, LLC
- $1.47 Trillion
- Q4 2024
A detailed history of Heck Capital Advisors, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 500 shares of HRMY stock, worth $19,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$19,385% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
245Shares Held
45.6MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$435 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$226 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$135 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$101 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.4 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.29B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...